Skip to content

Alaris, SmartSite 2451-0007Recalls & reported problems

BD Switzerland Sàrl · Pump Infusion Set, 3 Back Check Valves, 5 Y-Sites, 340 cm (134 in) · Class 2

All models of Alaris, SmartSite (160)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10885403220432), received between Sep 26, 2018 and Sep 26, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Break1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 26, 2018Break; Break

    THE CUSTOMER REPORTED THAT A MAINLINE OF LACTATED RINGER WAS PROGRAMMED AT 20/HR. DURING AN ENDOSCOPY PROCEDURE. THE PATIENT RECEIVED IV SEDATION OF MIDAZOLAM AND FENTANYL AND THEN WAS GIVEN A MANUAL FLUSH 10ML NORMAL SALINE. APPROXIMATELY 30 MIN LATER THE USER NOTICED SET "BLEW APART¿ AT AN UNSPECIFIED LOCATION. THERE WAS NO REPORT OF PATIENT HARM.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7910729 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page